Home |
Free Dividend Report |
Stock Splits Calendar |
BEAM Historical Stock Prices |
Preferred Stock Newsletter |
BEAM Options Chain |
Stock Message Boards |
Beam Therapeutics (BEAM) has the following price history information. Looking back at BEAM historical stock prices for the last five trading days, on April 16, 2024, BEAM opened at $25.23, traded as high as $25.90 and as low as $24.84, and closed at $25.70. Trading volume was a total of 1.68M shares. On April 17, 2024, BEAM opened at $26.06, traded as high as $26.14 and as low as $24.14, and closed at $24.31. Trading volume was a total of 1.44M shares. On April 18, 2024, BEAM opened at $24.19, traded as high as $24.78 and as low as $24.05, and closed at $24.31. Trading volume was a total of 1.71M shares. On April 19, 2024, BEAM opened at $24.14, traded as high as $24.94 and as low as $23.64, and closed at $23.90. Trading volume was a total of 4.54M shares. On April 22, 2024, BEAM opened at $24.27, traded as high as $24.27 and as low as $23.20, and closed at $24.10. Trading volume was a total of 2.43M shares.
BEAM Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Beam Therapeutics shares, starting with a $10,000 purchase of BEAM, and working forward through the historical stock price information to today.
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 02/06/2020 | |
End date: | 04/22/2024 | |
Start price/share: | $18.75 | |
End price/share: | $24.10 | |
Dividends collected/share: | $0.00 | |
Total return: | 28.53% | |
Average Annual Total Return: | 6.15% | |
Starting investment: | $10,000.00 | |
Ending investment: | $12,855.15 | |
Years: | 4.21 |
BEAM Historical Price Range | |||||
Date | Open | High | Low | Close | Volume |
04/16/2024 | $25.23 | $25.90 | $24.84 | $25.70 | 1.68M |
04/17/2024 | $26.06 | $26.14 | $24.14 | $24.31 | 1.44M |
04/18/2024 | $24.19 | $24.78 | $24.05 | $24.31 | 1.71M |
04/19/2024 | $24.14 | $24.94 | $23.64 | $23.90 | 4.54M |
04/22/2024 | $24.27 | $24.27 | $23.20 | $24.10 | 2.43M |
About Beam Therapeutics |
Beam Therapeutics is a biotechnology company. Co. has identified four development candidates to date: three from its ex vivo platform, with two candidates targeting hemoglobinopathies and one candidate targeting T-cell leukemia, and one from its in vivo platform targeting glycogen storage disease. BEAM-102 directly corrects the causative mutation in sickle cell disease by recreating a naturally-occurring normal human hemoglobin variant, HbG-Makassar. BEAM-201 is an anti-CD7, multiplex edited, allogeneic chimeric antigen receptor T cell development candidate for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia. |
BEAM Historical Closing Prices | |
Date | Close |
04/16/2024 | $25.70 |
04/17/2024 | $24.31 |
04/18/2024 | $24.31 |
04/19/2024 | $23.90 |
04/22/2024 | $24.10 |
Consumer Historical Prices |
BEAM is categorized under the Consumer sector; below are some other companies in the same sector:
BETR Historical Stock Prices
Free BEAM Email Alerts:
|
BEAM Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.Want to receive our latest research absolutely free?
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.